Underperformance In A Volatile Month, Top Decile Rankings Retained For Three And Five Year Periods

While this month was graced with favorable Q1FY23 results across sectors and continued retracting inflation rates, it was faced with several headwinds such as rate hikes by RBI, fear of recession, and uncertainties in global monetary policies. In this month, the broader markets ended with ~ 4.81% returns following a strong July 22 with 9.76% returns. We  generated ~ 2.78% returns in this month, underperforming the benchmark BSE500 TRI.  However, September has started well for us and we are tracking for decent outperformance in September till date.

We continue to rank among the best for the long term performance. For the five year period ending August 2022, we are ranked 6th out of 60 multicap PMSes. For the three year period ending August 2022, we are ranked 9th  out of  102 multicap PMSes reporting to PMS Bazaar.  We point out that our performance is net of all the fees as against a possible practice followed by some funds of collecting performance fees outside of the fund as per individual arrangement with the clients.

As defined by our strategy, we have maintained relatively higher levels of cash (14% on average over the entire period from inception) from time to time over the duration of managing the portfolio. Notwithstanding the same, from inception as well as over five and three years respectively, we have generated returns of 20.15%, 18.20% and 31.09% beating the benchmark BSE500 TRI returns of 16.10%, 13.59% and 21.26% respectively.

Portfolio Returns

The market rally at the end of July 2022 seems to have continued for the month of August 2022. For this month, the broader market ended on 4.81% returns. BSE Midcap TRI and BSE Smallcap TRI returned 5.76% and 6.05%, respectively.  August 2022 saw an impressive performance by many sectors, the star being the Banking sector generating ~ 7% returns. This was mainly driven by benign credit cost expectations and an improvement in credit growth with the economy picking up. Among other sectors that delivered better performance this month are Oil and Gas, Capital Goods, Aviation, and Metals. However, the IT and Pharma sectors underperformed the index for the second month in succession.  This is mainly due to the recession fears in the U.S markets. For this month, Sameeksha PMS has underperformed the benchmark by generating ~ 2.78% returns. While we could sufficiently participate in the Banking sector rally, our performance was affected by the IT and Pharma sectors. In addition, our allocation to other sectors that performed well this month was not signifcant enough to reap the fruits of this month’s bull run. 

While our returns are significant for longer periods, we are not happy with our performance over the last one year. Much of the underperformance for the last one year ending August 2022 is attributed to our performance for the last financial year and the same is discussed in our annual investor letter, including what did and did not work well for us. 

As can be observed in Table 1, we have strongly outperformed our benchmark index across all the other relevant key periods – 

Performance Within The PMS Universe

We continue to maintain our top rankings both within the multicap PMS universe as well as the entire PMS universe for key periods of three and five years. The multicap PMS universe rankings are more relevant to us since we follow multicap strategy.

For the three year period, we are ranked 9th out of 102 PMSes. Further, we are ranked 6th out of 60 funds for the five year period comparison within the Multicap universe – highlighting our superior performance over the long term (Table 2).

When compared with the entire PMS universe, we have maintained top rankings for longer key periods. We are consistently ranked in the Top Decile for the three year period and for the five year period (Table 3).

Rolling Returns And Rankings

Rolling returns are a more useful indicator of consistency in performance versus single period returns. For the rolling three year periods applicable for our entire operating history, we have been ranked among the multicap universe in the top decile 68.3% of the time (28 out of 41 observations) and in top Quartile 90% of the time (37 out of 41 observations). For the remaining 10% observations, we were ranked in the second quartile (Tables 4 and 5).  Also, for the three year period, we have remained in top decile every single month on a consecutive basis for almost two years since July 2020. Similarly, for the rolling five year periods applicable for our entire operating history, we have been ranked among the multicap universe in the Top Decile 100% of the time (18 out of 18 observations)

Performance Of Individual Portfolios

Portfolio returns for clients, except for investors starting with us over the last one year have seen remarkably strong alpha (Table 6). For a long term investor, Sameeksha PMS has proven to be a valuable partner for their investments. Performance of portfolios of clients who joined us in the last one year is a matter of concern that we hope to be able to address over time. We have discussed in detail about our average performance in the last one year in our annual investor letter

Our NRI clients have seen strong returns even after factoring in rupee depreciation against US dollars. The portfolio returns are significantly higher than both BSE 500 TRI and S&P 500 TRI, generating strong alpha over both these indices (Table 7).

Cumulative Performance Versus The Benchmark

Sameeksha’s outperformance over its benchmark has continued to widen positively over the years. Even after factoring in the underperformance and the volatile market in the last one year, an investment of Rs. 100 with us since inception (April 2016) would have grown to Rs. 325, far outpacing what one would have earned by investing in a fund that achieved benchmark returns (Figure 1).

Fund Performance On A Financial Year And Calendar Year Basis

For the first 5 months of the current financial year ending March 2023 (April 2022 to August 2022), Sameeksha PMS has underperformed the benchmark BSE 500 TRI by generating 0.8% returns for the period against the benchmark 4.1% returns (Table 8). 

Looking at our performance over the financial years, we have outperformed our benchmark in four out of seven financial years.  Key however is that the sum of outperformance in those four years far exceeds the sum of underperformance in the remaining three years (including the current incomplete financial year)

The performance pattern on a calendar year basis has been quite similar as well (Table 9). Although, for the current calendar year 2022, we are underperforming the benchmark, for the recently completed calendar year ending 2021, we have generated a return of 48.2% with an alpha of 16.6% over our benchmark BSE 500 TRI.

Risk Adjusted Ratios

When compared on a risk-adjusted basis (Table 10), our PMS shows even stronger performance with a risk-adjusted alpha generation of 8.6% over the broad market benchmark since its inception. While our portfolio beta has been materially lower than our benchmark, our returns have been higher than the benchmark since inception, implying superior strong risk adjusted returns. 

Furthermore, other risk-adjusted returns – Sharpe ratio and Treynor ratio, are also significantly higher than the benchmark indices (Table 10). It is worth noting that we offer superior risk adjusted returns not only compared to the broad BSE 500 index heavily weighted towards large cap but also the small cap and mid cap benchmarks as demonstrated by our Sharpe ratio, Alpha, Treynor ratio and Beta. 

Disclaimer : The information contained in this update is based on data provided by our fund accounting platform and is not audited

Among The Most Successful Professionals In Equities; Rated The #1 Technology Sector Analyst In Institutional Investors Polls For A Decade. Highly Respected Among Peers For His Path-Breaking Work And Thought Leadership. Rose From An Associate To Managing Director Within A Span Of Six Years In The Investment Banking Industry

Twenty Years Of Experience Building Top Research Franchises: Seven Years As Managing Director And The Global Head Of Technology At JP Morgan, Six Years As Director And Head Of Asia Pacific Technology At Credit Suisse And Five Years As Founder Of Equirus SecuritiesTrack Record Of Innovation And Excellence In Equity Research

Anchored The Rise Of Credit Suisse  From An Unknown Name In Asian Equities To A Number One Ranked Firm In Asian Equities; Head Of Asia Pacific Tech Research

Credited For Building Top Ranked Global As Well As Asian Tech Research Practice At JP Morgan As MD And Global Head Of Tech Research; Made Defining Contribution To Enable JPMorgan To Move From An Also-Ran Player To A Top Global Name In Equity Research

Built A Very Profitable And Award Winning Indian Equity Business At Equirus From Scratch On A Tiny Budget; Achieved Number Two Ranking In Asia For Idea Performance

Impeccable Track Record Of Identifying True Long Term Winners Ahead Of Others Including Samsung Electronics, TSMC, Infosys And TCS And Guiding Investors To Stay Clear Of Laggards Such As UMC And SMIC Years Ahead Of Consensus.

Mind Of An Engineer, Worked In A Team That Designed The World’s Fastest Microprocessor With A Manta “Paranoia Is The Safest Frame Of Mind”. Awarded Two US Patents.

Work Experience Of Designing The World’s Fastest Microprocessors Based On Cutting Edge Technology For Which He Jointly Holds Two US Patents

Best In Class Business Education From The World Renowned Business School: Double Major In Economics And Finance, Beta Gamma Sigma Cum Laude From The University Of Chicago Booth. Excelled In Studies Under World Renowned Faculty Such As Dr. Raghuram Rajan, Former Governor Of The Reserve Bank Of India